Amphetamine
Amphetamine is an active ingredient in 23 FDA-listed drug products sold under 4 names.
Drugs containing Amphetamine
Products and strengths
| NDC | Product | Strength | Labeler |
|---|---|---|---|
| 70165-015 | Adzenys XR-ODT Tablet, Orally Disintegrating | 9.4 mg/1 | Neos Therapeutics Brands, LLC |
| 70165-005 | Adzenys XR-ODT Tablet, Orally Disintegrating | 3.1 mg/1 | Neos Therapeutics Brands, LLC |
| 70165-025 | Adzenys XR-ODT Tablet, Orally Disintegrating | 15.7 mg/1 | Neos Therapeutics Brands, LLC |
| 70165-030 | Adzenys XR-ODT Tablet, Orally Disintegrating | 18.8 mg/1 | Neos Therapeutics Brands, LLC |
| 70165-020 | Adzenys XR-ODT Tablet, Orally Disintegrating | 12.5 mg/1 | Neos Therapeutics Brands, LLC |
| 70165-010 | Adzenys XR-ODT Tablet, Orally Disintegrating | 6.3 mg/1 | Neos Therapeutics Brands, LLC |
| 0480-3317 | Amphetamine Tablet, Orally Disintegrating | 9.4 mg/1 | Teva Pharmaceuticals, Inc. |
| 0480-3318 | Amphetamine Tablet, Orally Disintegrating | 12.5 mg/1 | Teva Pharmaceuticals, Inc. |
| 0480-3316 | Amphetamine Tablet, Orally Disintegrating | 6.3 mg/1 | Teva Pharmaceuticals, Inc. |
| 0480-3319 | Amphetamine Tablet, Orally Disintegrating | 15.7 mg/1 | Teva Pharmaceuticals, Inc. |
| 0480-3315 | Amphetamine Tablet, Orally Disintegrating | 3.1 mg/1 | Teva Pharmaceuticals, Inc. |
| 0480-3320 | Amphetamine Tablet, Orally Disintegrating | 18.8 mg/1 | Teva Pharmaceuticals, Inc. |
| 62542-005 | Amphetamine Extended-Release Tablet, Orally Disintegrating | 3.1 mg/1 | Neos Therapeutics, LP |
| 62542-020 | Amphetamine Extended-Release Tablet, Orally Disintegrating | 12.5 mg/1 | Neos Therapeutics, LP |
| 62542-025 | Amphetamine Extended-Release Tablet, Orally Disintegrating | 15.7 mg/1 | Neos Therapeutics, LP |
| 62542-030 | Amphetamine Extended-Release Tablet, Orally Disintegrating | 18.8 mg/1 | Neos Therapeutics, LP |
| 62542-015 | Amphetamine Extended-Release Tablet, Orally Disintegrating | 9.4 mg/1 | Neos Therapeutics, LP |
| 62542-010 | Amphetamine Extended-Release Tablet, Orally Disintegrating | 6.3 mg/1 | Neos Therapeutics, LP |
| 24478-109 | Dyanavel Xr Tablet, Extended Release | 15 mg/1 | NextWave Pharmaceuticals, Inc |
| 24478-102 | Dyanavel XR Suspension, Extended Release | 2.5 mg/mL | NextWave Pharmaceuticals, Inc |
| 24478-106 | Dyanavel Xr Tablet, Extended Release | 5 mg/1 | NextWave Pharmaceuticals, Inc |
| 24478-108 | Dyanavel Xr Tablet, Extended Release | 10 mg/1 | NextWave Pharmaceuticals, Inc |
| 24478-110 | Dyanavel Xr Tablet, Extended Release | 20 mg/1 | NextWave Pharmaceuticals, Inc |